Abstract
Background: Cephamycins prophylactic used in colorectal surgery have been widely evaluated, but the uncertainty remains about the comparative effects of different antibiotics. The meta-analysis aimed to assess the efficacy of cephamycins compared with other agents used as prophylaxis in colorectal surgery.Methods: PubMed, EMBASE, and Cochrane Library were searched for relevant studies. A meta-analysis of randomized controlled trials (RCTs) meeting the criteria was performed using Review Manager.Results: Thirty-nine trials involving 4,755 participants were included in this meta-analysis. The cephamycins were not as effective as other antibiotics for the prevention of postoperative surgical site infection (SSI) (Risk Ratio [RR] 1.18; 95% confidence interval [CI] 1.04, 1.34; P=0.008) and had no advantages in reduction of systemic infection and distal infection. For each antibiotic belonging to cephamycins, there was no statistical difference when cefoxitin and cefotetan were compared with penicillins and cephalosporins on prevention of SSI, while cefmetazole had advantages over cephalosporins on prevention of SSI (RR 0.46; 95% CI 0.22, 0.96; P=0.04).Conclusions: The prophylactic use of cefoxitin and cefotetan in colorectal operations has no significant advantages over other antibiotics. However, cefmetazole may be effective in the prevention of postoperative infections and its efficacy should be researched further and considered by perioperative medical staff. Therefore, it is of great importance to optimize the prophylactic use of antibiotics in colorectal operations. Citation: Yu Ding, Feng-Ying Xu, Miao Zhou, Yu- Xin Li, Hua He, Xue- Peng Zhang, et al. Assessing prophylacticcephamycins used in colorectal surgery: a meta- analysis. J Anesth Perioper Med 2015; 2: 75-86. doi: 10.24015/JAPM.2015.0012This is an open-access article, published by Evidence Based Communications (EBC). This work is licensed under the Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium or format for any lawful purpose. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.